The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia
- PMID: 28061852
- PMCID: PMC5219782
- DOI: 10.1186/s12941-016-0177-6
The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia
Abstract
Background: The infection and prevalence of extended-spectrum β-lactamases (ESBLs) is a worldwide problem, and the presence of ESBLs varies between countries. In this study, we investigated the occurrence of plasmid-mediated ESBL/AmpC/carbapenemase/aminoglycoside resistance gene expression in Escherichia coli using phenotypic and genotypic techniques.
Methods: A total of 58 E. coli isolates were collected from hospitals in the city of Makkah and screened for the production of ESBL/AmpC/carbapenemase/aminoglycoside resistance genes. All samples were subjected to phenotypic and genotypic analyses. The antibiotic susceptibility of the E. coli isolates was determined using the Vitek-2 system and the minimum inhibitory concentration (MIC) assay. Antimicrobial agents tested using the Vitek 2 system and MIC assay included the expanded-spectrum (or third-generation) cephalosporins (e.g., cefoxitin, cefepime, aztreonam, cefotaxime, ceftriaxone, and ceftazidime) and carbapenems (meropenem and imipenem). Reported positive isolates were investigated using genotyping technology (oligonucleotide microarray-based assay and PCR). The genotyping investigation was focused on ESBL variants and the AmpC, carbapenemase and aminoglycoside resistance genes. E. coli was phylogenetically grouped, and the clonality of the isolates was studied using multilocus sequence typing (MLST).
Results: Our E. coli isolates exhibited different levels of resistance to ESBL drugs, including ampicillin (96.61%), cefoxitin (15.25%), ciprofloxacin (79.66%), cefepime (75.58%), aztreonam (89.83%), cefotaxime (76.27%), ceftazidime (81.36%), meropenem (0%) and imipenem (0%). Furthermore, the distribution of ESBL-producing E. coli was consistent with the data obtained using an oligonucleotide microarray-based assay and PCR genotyping against genes associated with β-lactam resistance. ST131 was the dominant sequence type lineage of the isolates and was the most uropathogenic E. coli lineage. The E. coli isolates also carried aminoglycoside resistance genes.
Conclusions: The evolution and prevalence of ESBL-producing E. coli may be rapidly accelerating in Saudi Arabia due to the high visitation seasons (especially to the city of Makkah). The health authority in Saudi Arabia should monitor the level of drug resistance in all general hospitals to reduce the increasing trend of microbial drug resistance and the impact on patient therapy.
Keywords: E. coli; ESBL; Genotyping; K. pneumonia; Phenotyping; Saudi Arabia.
Figures
Similar articles
-
In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.Antimicrob Agents Chemother. 2015 Dec;59(12):7483-8. doi: 10.1128/AAC.01804-15. Epub 2015 Sep 21. Antimicrob Agents Chemother. 2015. PMID: 26392491 Free PMC article.
-
Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.Int J Infect Dis. 2008 May;12(3):256-64. doi: 10.1016/j.ijid.2007.08.008. Epub 2007 Nov 5. Int J Infect Dis. 2008. PMID: 17981482
-
Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.Appl Environ Microbiol. 2020 Jul 20;86(15):e00742-20. doi: 10.1128/AEM.00742-20. Print 2020 Jul 20. Appl Environ Microbiol. 2020. PMID: 32471914 Free PMC article.
-
Extended-spectrum plasmid-mediated beta-lactamases.J Antimicrob Chemother. 1995 Jul;36 Suppl A:19-34. doi: 10.1093/jac/36.suppl_a.19. J Antimicrob Chemother. 1995. PMID: 8543494 Review.
-
Decadal Analysis of ESBL-Escherichia coli Antibiotic Resistance Patterns in Urine Samples from Nepal: A Systematic Review and Meta-Analysis.J Nepal Health Res Counc. 2024 Mar 22;21(3):353-365. doi: 10.33314/jnhrc.v21i3.4723. J Nepal Health Res Counc. 2024. PMID: 38615204
Cited by
-
Antibiotic-Resistance Genes in E. coli strains in GCC Countries: A Meta-Analysis.Saudi J Med Med Sci. 2022 Jan-Apr;10(1):1-11. doi: 10.4103/sjmms.sjmms_638_21. Epub 2022 Jan 17. Saudi J Med Med Sci. 2022. PMID: 35283714 Free PMC article.
-
Drug resistance, AmpC-β-lactamase and extended-spectrum β-lactamase-producing Enterobacteriaceae isolated from fish and shrimp.Rev Inst Med Trop Sao Paulo. 2017 Nov 6;59:e70. doi: 10.1590/S1678-9946201759070. Rev Inst Med Trop Sao Paulo. 2017. PMID: 29116290 Free PMC article.
-
High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Amhara region.PLoS One. 2019 Apr 15;14(4):e0215177. doi: 10.1371/journal.pone.0215177. eCollection 2019. PLoS One. 2019. PMID: 30986262 Free PMC article. Clinical Trial.
-
Prevalence of E. coli ST131 among Uropathogenic E. coli Isolates from Iraqi Patients in Wasit Province, Iraq.Int J Microbiol. 2020 Oct 16;2020:8840561. doi: 10.1155/2020/8840561. eCollection 2020. Int J Microbiol. 2020. PMID: 33133190 Free PMC article.
-
Prevalence and molecular characteristics of sequence type 131 clone among clinical uropathogenic Escherichia coli isolates in Riyadh, Saudi Arabia.Saudi J Biol Sci. 2020 Jan;27(1):296-302. doi: 10.1016/j.sjbs.2019.09.020. Epub 2019 Sep 18. Saudi J Biol Sci. 2020. PMID: 31889850 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
